Scroll Top


Professional Experience

01/03/2023 – Present day: Visiting Scholar at Lenox Hill Hospital Department of Gynecologic Oncology, New York 

01/11/2019 – 14/02/2023: Hygeia Hospital, 5th Medical Oncology Clinic, Medical Oncologist

2022: Recipient of Hellenic Society of Medical Oncology (HeSMO) postgraduate scholarship 

28/09/2019: Successfully Passed ESMO Examination for Medical Oncology

29/08/2019: Successfully Passed Hellenic Examination for Medical Oncology

06/2016 – 07/2019: Alexandra Hospital, Department of Clinical Therapeutics of University of Athens, Hematology/Oncology Unit, resident in Medical Oncology.

07/2015 – 01/2016: General Hospital of Larissa, Health Center of Agia, Rural Service.

12/2012 – 06/2013: University Hospital of Larissa, Hematology Unit, resident in Hematology.

09/2010 – 12/2012: General Hospital of Lamia, Internal Medicine Clinic, resident in Internal Medicine.

03/2010 – 09/2010: General Hospital of Larissa, Health Center of Agia, Rural Service.

08/2009 – 02/2010: Service as a physician without specialization at Recovery and Rehabilitation Center “ANIMUS” 

Published Work


Participation in the translation of the ESMO Guide for patients: Cervical Cancer


Risk for Arterial Thromboembolic Events (ATEs) in Patients with Advanced Urinary Tract Cancer (aUTC) Treated with First-Line Chemotherapy: Single-Center, Observational Study
Bamias A, Tzannis K, Zakopoulou R, Sakellakis M, Dimitriadis J, Papatheodoridi A, Rallidis L, Halvatsiotis P, Tsiara A, et al
Curr Oncol. 2022 Aug 24;29(9):6077-6090. doi: 10.3390/curroncol29090478


Participation in the translation of the ESMO Guide for patients: Ovarian Cancer


The Role of the Hippo Pathway in Breast Cancer Carcinogenesis, Prognosis, and Treatment: A Systematic Review.
Kyriazoglou A, Liontos M, Zakopoulou R, Kaparelou M, Tsiara A, et al
Breast Care (Basel). 2021 Feb;16(1):6-15.


Risk for Venous Thromboembolic Events in Patients With Advanced Urinary Tract Cancer Treated With First-Line Chemotherapy.

Bamias A, Tzannis K, Dimitriadis I, Tsironis G, Papatheorodidi AM, Tsiara A, et al

Clin Genitourin Cancer. 2020 Aug;18(4):e457-e472.


Lymphocytic infiltration and Chemotherapy Response Score as prognostic markers in ovarian cancer patients treated with Neoadjuvant chemotherapy.
Liontos M, Sotiropoulou M, Kaparelou M, Tzannis K, Tsironis G, Kyriazoglou A, Tsiara A, et al
Gynecol Oncol. 2020 Jun;157(3):599-605.


Axitinib as a third or further line of treatment in renal cancer: a single institution experience.
Tsironis G, Liontos M, Kyriazoglou A, Koutsoukos K, Tsiara A, et al
BMC Urol. 2020 Jun 2;20(1):60.


Facing internet fake-medicine and web para-pharmacy in the total absence of official recommendations from medical societies.
Mauri D, Tsali L, P Polyzos N, Valachis A, Zafeiria G, Kalopita K, Tsiara A, et al J BUON. 2019 Jul-Aug;24(4):1314-1325.


Global coverage and consistency of guideline recommendations for cancer cachexia on the Web in 2011 and 2018.
Mauri D, Zafeiri G, Yerolatsite M, Tsali L, Zarkavelis G, Tsiara A, et al
Contemp Oncol (Pozn). 2019;23(2):100-109. doi: 10.5114/wo.2019.85882. Epub 2019 Jun 13.


Management of uterine sarcomas and prognostic indicators: real world data from a single-institution.

Kyriazoglou A, Liontos M, Ziogas DC, Zagouri F, Koutsoukos K, Tsironis G, Tsiara A, et al

BMC Cancer. 2018 Dec 13;18(1):1247. doi: 10.1186/s12885-018-5156-1. 


Patterns of practice and pharmacoeconomic analysis of the management of patients with metastatic renal cell carcinoma (mRCC) in Greece--the CRISIS study. A retrospective analysis by the Hellenic Genitourinary Cancer Group (HGUCG).

Tsironis G, Koutsoukos K, Athanasakis K, Tsiara A, et al

Expert Rev Pharmacoecon Outcomes Res. 2019 Aug;19(4):491-501. doi: 10.1080/14737167.2019.1546121. Epub 2018 Nov 19.


Implementation of immunotherapy in the treatment of advanced non-small cell lung cancer (NSCLC).

Tsiara A, Liontos M, Kaparelou M, et al

Ann Transl Med 2018 Apr;6(8):144


Treating ALK-positive non-small cell lung cancer.
Ziogas DC, Tsiara A, Tsironis G, et al
Ann Transl Med 2018 Apr;6(8):141


“Breast Cancer” in “Advances in Clinical Therapeutics 2018”, pages 167-170, Epistimon Publications, ISBN 978-618-83535-1-0.


“Solid Tumors” in “Advances in Clinical Therapeutics 2017”, pages 267- 279, Epistimon Publications, ISBN 978-618-81870-7-8.


Cancer cachexia: global awareness and guideline implementation on the web

Mauri D, Tsiara A, Valachis A, et al

BMJ Supportive & Palliative Care 2013;3:155-160.


Recurrent multi-loculated symptomatic malignant pleural effusion after talc pleurodesis: drain and re-drain improve quality of life and patient survival” (case report)
Tsiara A, Tsali L, Valachis A, et al
Forum of Clinical Oncology 2011; Vol 2:44-47

2013 – 2015: MSc «Clinicopathological study of human neoplasms» Medical School, National and Kapodistrian University of Athens, Thesis pending 

2002 – 2008: MD, Medical School, University of Patras, Degree: 6,77 / 10.

2016 – 2019: Subinvestigator in clinical trials conducted in Hematology/ Oncology Unit of Clinical Therapeutics Department of University of Athens, Alexandra Hospital (NCT02626013, CBYL719C2301, AB12003, CPZP034AGR06, CRAD001CGR12, YO39523, CompLEEment-1)

23-24/11/2018: ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2018: Zurich

25 – 26/04/2015: Successfully completed ALS (Advanced Life Support) course, Athens.

Posters at International – Panhellenic Conferences

27-01/10/2019 ESMO 

Poster: Expression analysis of NHEJ and HR genes in Ewing sarcomas: indications of DSB repair dysfunction.
A Kyriazoglou, V Konteles, M Liontos, G Sofianidis, F Zagouri, K Koutsoukos, G Tsironis, A Tsiara, et al.

18-20/04/2019 25o ΕΣΚΟ

“Νευροενδοκρινή Νεοπλάσματα Γυναικολογικού Συστήματος: Εμπειρία ενός Κέντρου” (Neuroendocrine neoplasms of female reproductive system: A single-center experience) Α. Τσιάρα, Μ. Λιόντος, Κ. Κουτσούκος, Γ. Τσιρώνης, Φ. Ζαγουρή, Α. Κυριαζόγλου, Μ. Καπαρέλου, Ρ. Ζακοπούλου, Α. Κοέν, Μ.Α. Δημόπουλος, Α. Μπάμιας

18-20/04/2019 25o ΕΣΚΟ

“Μελέτη Αποτελεσματικότητας και ασφάλειας του AXITINIB μετά τη δεύτερη γραμμή θεραπείας σε ασθενείς με μεταστατικό καρκίνο νεφρού”
Γ. Τσιρώνης, Α. Κυριαζόγλου, Μ. Λιόντος, Κ. Κουτσούκος, Α. Τσιάρα, Μ. Καπαρέλου, Ρ. Ζακοπούλου, Α. Κοέν, Φ. Ζαγουρή, Μ.Α. Δημόπουλος, Α. Μπάμιας

4  18-20/04/2019 25o ΕΣΚΟ

“Η Θεραπεία του μεταστατικού ευνουχοάντοχου καρκίνου προστάτη mCRPC σε ηλικιωμένους. Μια αναδρομική μελέτη ενός κέντρου”
Α. Σβάρνα, Ρ. Ζακοπούλου, Μ. Λιόντος, Μ. Καπαρέλου, Α. Τσιάρα, Α. Κυριαζόγλου, Α. Κοέν, Γ. Τσιρώνης, Κ. Κουτσούκος, Φ. Ζαγουρή, Α. Μπάμιας, Μ.Α. Δημόπουλος

18-20/04/2019 25o ΕΣΚΟ

“Αναδρομική ανάλυση της εμφάνισης συμπτωμάτων από τις αρθρώσεις σε ασθενείς με επιθηλιακό καρκίνο ωοθηκών που λαμβάνουν θεραπεία με BEVACIZUMAB. Συσχέτιση με την έκβαση της θεραπείας και την επιβίωση” Μ. Καπαρέλου, Μ. Λιόντος, Κ. Τζάνης, Π. Κατσιμπρή, Α. Τσιάρα, Α. Κυριαζόγλου, Ρ. Ζακοπούλου, Α. Κοέν, Φ. Ζαγουρή, Κ. Κουτσούκος, Γ. Τσιρώνης, Δ. Βλάχος, Ν. Θωμάκος, Δ. Χαϊδόπουλος, Α. Ροδολάκης, Μ.Α. Δημόπουλος, Α. Μπάμιας


6 18 – 19/11/2016

“A retrospective study of vascular thrombotic events in patients receiving first-line treatment for advanced urothelial cancer. G.Tsironis, I. Dimitriadis, K.Koutsoukos, M. Liontos, M. Lykka, F. Zagouri, A. Tsiara, M. Kaparelou, A. Sfika, K. Nikolopoulos, A. Xirokosta, E. Eleutherakis, M. Migkou, D. Mparmparousi, H. Matsouka, MA Dimopoulos, A. Mpamias, “Challenges in the Application of Guidelines in Genitourinary Cancer”, Athens. Study received the second award “Konstantinos Dimopoulos”.